These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

504 related items for PubMed ID: 9467543

  • 21. [Effect of treatment with gonadotropin releasing hormone analogues in girls with idiopathic central precocious puberty].
    Ságodi L, Sólyom E, Lombay B, Almási A, Vámosi I.
    Orv Hetil; 2012 Mar 18; 153(11):418-24. PubMed ID: 22390866
    [Abstract] [Full Text] [Related]

  • 22. The effect of gonadotrophin-releasing hormone agonist treatment over 3 years on bone mineral density and body composition in girls with central precocious puberty.
    Park HK, Lee HS, Ko JH, Hwang IT, Lim JS, Hwang JS.
    Clin Endocrinol (Oxf); 2012 Nov 18; 77(5):743-8. PubMed ID: 22530679
    [Abstract] [Full Text] [Related]

  • 23. Alterations in bone turnover and impaired development of bone mineral density in newly diagnosed children with cancer: a 1-year prospective study.
    Arikoski P, Komulainen J, Riikonen P, Voutilainen R, Knip M, Kröger H.
    J Clin Endocrinol Metab; 1999 Sep 18; 84(9):3174-81. PubMed ID: 10487683
    [Abstract] [Full Text] [Related]

  • 24. Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial.
    Willemsen RH, Arends NJ, Bakker-van Waarde WM, Jansen M, van Mil EG, Mulder J, Odink RJ, Reeser M, Rongen-Westerlaken C, Stokvis-Brantsma WH, Waelkens JJ, Hokken-Koelega AC.
    Clin Endocrinol (Oxf); 2007 Oct 18; 67(4):485-92. PubMed ID: 17561977
    [Abstract] [Full Text] [Related]

  • 25. Bone metabolism markers and ghrelin in boys at different stages of sexual maturity.
    Jürimäe J, Pomerants T, Tillmann V, Jürimäe T.
    Acta Paediatr; 2009 May 18; 98(5):892-6. PubMed ID: 19243352
    [Abstract] [Full Text] [Related]

  • 26. Bone mineral density, bone metabolism and body composition of children with chronic renal failure, with and without growth hormone treatment.
    Boot AM, Nauta J, de Jong MC, Groothoff JW, Lilien MR, van Wijk JA, Kist-van Holthe JE, Hokken-Koelega AC, Pols HA, de Muinck Keizer-Schrama SM.
    Clin Endocrinol (Oxf); 1998 Nov 18; 49(5):665-72. PubMed ID: 10197084
    [Abstract] [Full Text] [Related]

  • 27. Effects of suppression of estrogen action by the p450 aromatase inhibitor letrozole on bone mineral density and bone turnover in pubertal boys.
    Wickman S, Kajantie E, Dunkel L.
    J Clin Endocrinol Metab; 2003 Aug 18; 88(8):3785-93. PubMed ID: 12915670
    [Abstract] [Full Text] [Related]

  • 28. Bone mineral metabolism in girls with precocious puberty during gonadotrophin-releasing hormone agonist treatment.
    Antoniazzi F, Bertoldo F, Zamboni G, Valentini R, Sirpresi S, Cavallo L, Adami S, Tatò L.
    Eur J Endocrinol; 1995 Oct 18; 133(4):412-7. PubMed ID: 7581963
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Effects of 12 months rec-GH therapy on bone and collagen turnover and bone mineral density in GH deficient children with thalassaemia major.
    Sartorio A, Conte G, Conti A, Masala A, Alagna S, Rovasio P, Faglia G.
    J Endocrinol Invest; 2000 Jun 18; 23(6):356-61. PubMed ID: 10908162
    [Abstract] [Full Text] [Related]

  • 31. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: a 1-year prospective study.
    Marinovic D, Dorgeret S, Lescoeur B, Alberti C, Noel M, Czernichow P, Sebag G, Vilmer E, Léger J.
    Pediatrics; 2005 Jul 18; 116(1):e102-8. PubMed ID: 15995009
    [Abstract] [Full Text] [Related]

  • 32. Long-term observation of 87 girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogs: impact on adult height, body mass index, bone mineral content, and reproductive function.
    Pasquino AM, Pucarelli I, Accardo F, Demiraj V, Segni M, Di Nardo R.
    J Clin Endocrinol Metab; 2008 Jan 18; 93(1):190-5. PubMed ID: 17940112
    [Abstract] [Full Text] [Related]

  • 33. Decreased lumbar spine bone mass and low bone turnover in children and adolescents with insulin dependent diabetes mellitus followed longitudinally.
    Gunczler P, Lanes R, Paz-Martinez V, Martins R, Esaa S, Colmenares V, Weisinger JR.
    J Pediatr Endocrinol Metab; 1998 Jan 18; 11(3):413-9. PubMed ID: 11517957
    [Abstract] [Full Text] [Related]

  • 34. Bone mineral density and body composition in girls with idiopathic central precocious puberty before and after treatment with a gonadotropin-releasing hormone agonist.
    Alessandri SB, Pereira Fde A, Villela RA, Antonini SR, Elias PC, Martinelli CE, Castro Md, Moreira AC, Paula FJ.
    Clinics (Sao Paulo); 2012 Jan 18; 67(6):591-6. PubMed ID: 22760897
    [Abstract] [Full Text] [Related]

  • 35. Skeletal effects of two years of treatment with low physiological doses of recombinant human growth hormone (GH) in patients with adult-onset GH deficiency.
    Janssen YJ, Hamdy NA, Frölich M, Roelfsema F.
    J Clin Endocrinol Metab; 1998 Jun 18; 83(6):2143-8. PubMed ID: 9626153
    [Abstract] [Full Text] [Related]

  • 36. Final height outcome after three years of growth hormone and gonadotropin-releasing hormone agonist treatment in short adolescents with relatively early puberty.
    van Gool SA, Kamp GA, Visser-van Balen H, Mul D, Waelkens JJ, Jansen M, Verhoeven-Wind L, Delemarre-van de Waal HA, de Muinck Keizer-Schrama SM, Leusink G, Roos JC, Wit JM.
    J Clin Endocrinol Metab; 2007 Apr 18; 92(4):1402-8. PubMed ID: 17284626
    [Abstract] [Full Text] [Related]

  • 37. Bone mineral density in postmenarchal adolescent girls in the United States: associated biopsychosocial variables and bone turnover markers.
    Harel Z, Gold M, Cromer B, Bruner A, Stager M, Bachrach L, Wolter K, Reid C, Hertweck P, Nelson A, Nelson D, Coupey S, Johnson C, Burkman R, Bone H.
    J Adolesc Health; 2007 Jan 18; 40(1):44-53. PubMed ID: 17185205
    [Abstract] [Full Text] [Related]

  • 38. Biochemical bone markers and bone mineral density during postmenopausal hormone replacement therapy with and without vitamin D3: a prospective, controlled, randomized study.
    Heikkinen AM, Parviainen M, Niskanen L, Komulainen M, Tuppurainen MT, Kröger H, Saarikoski S.
    J Clin Endocrinol Metab; 1997 Aug 18; 82(8):2476-82. PubMed ID: 9253321
    [Abstract] [Full Text] [Related]

  • 39. Decreased bone mineral density and bone formation markers shortly after diagnosis of clinical type 1 diabetes mellitus.
    Gunczler P, Lanes R, Paoli M, Martinis R, Villaroel O, Weisinger JR.
    J Pediatr Endocrinol Metab; 2001 May 18; 14(5):525-8. PubMed ID: 11393573
    [Abstract] [Full Text] [Related]

  • 40. Effects of treatment with GH alone or in combination with LHRH analog on bone mineral density in pubertal GH-deficient patients.
    Mericq V, Gajardo H, Eggers M, Avila A, Cassorla F.
    J Clin Endocrinol Metab; 2002 Jan 18; 87(1):84-9. PubMed ID: 11788628
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.